Get the app
US › Healthcare

Regencell Bioscience Holdings Ltd (RGC)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$5.96+4.93%
Last close · 2026-09-17

Key statistics

Market cap
$2.72B
Forward P/E
0.0
P/B
2,234.44
Book value
$0.00
EPS (TTM)
$-0.01
52-week high
$69.00
52-week low
$4.51
50-day MA
$5.67
200-day MA
$19.72
Beta
1.43

Shareholding

Insiders
88.38%
Institutions
0.29%

Largest institutional holders

FundStake
Geode Capital Management, LLC0.08%
Quadrature Capital Limited0.01%
Marex Group Ltd0.01%
Vident Advisory, LLC0.01%
Squarepoint Ops LLC0.01%
UBS Group AG0.00%
Fox Run Management LLC0.00%
Morgan Stanley - Brokerage Accounts0.00%

Corporate actions

ActionDetailDate
Split38 : 1
effective Jun 16, 2025		2025-06-16

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Regencell Bioscience Holdings Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.